Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ibrutinib
ibrutinib
Tackling Cancer: Leukemia's Biggest Current and Upcoming Players
Motley Fool
Mon, 05/20/13 - 11:40 am
leukemia
Sprycel
Bristol-Myers Squibb
Gleevec
Novartis
Iclusig
Ariad Pharmaceuticals
Bosulif
Pfizer
Erwinaze
Jazz Pharmaceuticals
Idelalisib
Gilead
ibrutinib
Pharmacyclics
ASCO '13 Preview: Gilead's Big Cancer Debut
TheStreet.com
Thu, 05/16/13 - 08:54 am
Gilead
ASCO
JNJ
Pharmacyclics
idelalisab
ibrutinib
CLL
Pharmacyclics says FDA grants Breakthrough Therapy Designation for ibrutinib
Yahoo/Fly on the Wall
Mon, 04/8/13 - 11:05 am
FDA
Pharmacyclics
ibrutinib
CLL
The Wild Story Behind A Promising Experimental Cancer Drug
Forbes
Sat, 04/6/13 - 11:04 am
ibrutinib
Pharmacyclics
chronic lymphocytic leukemia
mantle cell lymphoma
JNJ
Abbott to work with J&J on genetic test for leukemia drug
Reuters
Thu, 02/21/13 - 11:52 am
JNJ
Abbott Labs
ibrutinib
chronic lymphocytic leukemia
Pharmacyclics jumps on drug approval plans
Yahoo/AP
Sat, 02/16/13 - 11:59 am
Pharmacyclics
ibrutinib
mantle cell lymphoma
Pharmacyclics Gains ‘Breakthrough’ Status for Cancer Drug
Bloomberg
Wed, 02/13/13 - 10:11 am
Pharmacyclics
ibrutinib
JNJ
Pharmacyclics And Promising Advances In Leukemia Treatment
Seeking Alpha
Thu, 12/13/12 - 11:36 am
Pharmacyclics
chronic lymphocytic leukemia
ibrutinib
Major Weekend Biotech Announcements Could Produce Gains on Monday
Motley Fool
Mon, 12/10/12 - 10:39 am
Pharmacyclics
JNJ
ibrutinib
Eliquis
Pfizer
Bristol-Myers Squibb
Pharmacyclics Blood-Cancer Drug Controls Disease in Study
Bloomberg
Sat, 12/8/12 - 11:06 am
chronic lymphocytic leukemia
ibrutinib
Pharmacyclics
Pharmacyclics slumps on disappointing study data
Yahoo/AP
Mon, 11/5/12 - 12:45 pm
Pharmacyclics
ibrutinib
JNJ
lymphoma
leukemia
Pharmacyclics shares continue climb as analysts project blockbuster sales for cancer drug
Yahoo/AP
Fri, 06/8/12 - 10:06 am
Pharmacyclics
ibrutinib
non-Hodgkin's lymphoma
chronic lymphocytic leukemia
2 Drug Combination Stocks Targeting Leukemia
Seeking Alpha
Wed, 05/23/12 - 12:04 pm
leukemia
Threshold Pharmaceuticals
Pharmacyclics
ibrutinib
chronic lymphocytic leukemia
TH-302
Pages
« first
‹ previous
1
2